Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection [...]
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO) Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech [...]
GenSpera Announces Partnership With Global Supplier Company to Partner with Phyton Biotech for Manufacture of the Key Ingredient in Mipsagargin SAN ANTONIO, Feb. 9, 2015 -- GenSpera, [...]
Phyton Biotech Receives CEP for Docetaxel API VANCOUVER, Canada--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to [...]
Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation VANCOUVER, British Columbia--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted [...]
Phyton Biotech Receives "Research Group of the Year" Award SAN ANTONIO--Phyton Biotech announced that it has won the international “Research Group of the Year” 2011 Life Science [...]
